Beta Drugs
13 May, 2024 14:33 BSE: 531481
NSE: BETAISIN: INE351Y01019
Start SIP in Beta Drugs
Start SIPBeta Drugs Performance
Day Range
- Low 1,280
- High 1,320
52 Week Range
- Low 660
- High 1,595
- Open Price1,300
- Previous Close1,271
- Volume3600
Beta Drugs Financials
Indicator |
---|
Oper Rev Qtr Cr |
Operating Expenses Qtr Cr |
Operating Profit Qtr Cr |
Depreciation Qtr Cr |
Interest Qtr Cr |
Tax Qtr Cr |
Net Profit Qtr Cr |
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,319.9
+49.3 (3.88%)
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹1,315.13
- 50 Day
- ₹1,309.79
- 100 Day
- ₹1,282.79
- 200 Day
- ₹1,182.42
- 20 Day
- ₹1,329.96
- 50 Day
- ₹1,284.49
- 100 Day
- ₹1,346.79
- 200 Day
- ₹1,177.57
Beta Drugs Resistance and Support
PIVOT
₹1,276.37
Resistance | |
---|---|
First Resistance | 1,294.23 |
Second Resistance | 1,317.87 |
Third Resistance | 1,335.73 |
RSI | 43.91 |
MFI | 32.80 |
MACD Single Line | 7.88 |
MACD | -3.13 |
Support | |
---|---|
First Resistance | 1,252.73 |
Second Resistance | 1,234.87 |
Third Resistance | 1,211.23 |
Beta Drugs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 1,900 | 159,999 | 84.21 |
Week | 3,480 | 251,987 | 72.41 |
1 Month | 3,663 | 279,462 | 76.29 |
6 Month | 4,630 | 347,250 | 75 |
Beta Drugs Result Highlights
Beta Drugs Synopsis
NSE-Medical-Diversified
Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 157.87 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2023. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.Market Cap | 1,266 |
Sales | 158 |
Shares in Float | 0.32 |
No of funds | 3 |
Yield |
Book Value | 12.69 |
U/D Vol ratio | 0.9 |
LTDebt / Equity | 4 |
Alpha | 0.09 |
Beta | 1.21 |
Beta Drugs
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 66.73% | 66.73% | 66.73% | 66.73% |
Foreign Portfolio Investors | 0.32% | 0.32% | 0.32% | 0.29% |
Individual Investors | 22.35% | 22.33% | 22.37% | 22.24% |
Others | 10.6% | 10.62% | 10.58% | 10.74% |
Beta Drugs Management
Name | Designation |
---|---|
Mr. Rahul Batra | Chairperson & Managing Director |
Mr. Varun Batra | Joint Managing Director |
Mr. Balwant Singh | Whole Time Director |
Mrs. Seema Chopra | Whole Time Director |
Mr. Ashutosh Shukla | Whole Time Director |
Mr. Rohit Parti | Independent Director |
Mr. Manmohan Khanna | Independent Director |
Beta Drugs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Beta Drugs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
2023-05-08 | Audited Results | |
2022-10-27 | Quarterly Results | |
2022-04-27 | Audited Results | |
2021-10-25 | Quarterly Results |
Beta Drugs FAQs
What is Share Price of Beta Drugs ?
Beta Drugs share price is ₹1,319 As on 13 May, 2024 | 14:19
What is the Market Cap of Beta Drugs ?
The Market Cap of Beta Drugs is ₹1268.9 Cr As on 13 May, 2024 | 14:19
What is the P/E ratio of Beta Drugs ?
The P/E ratio of Beta Drugs is As on 13 May, 2024 | 14:19
What is the PB ratio of Beta Drugs ?
The PB ratio of Beta Drugs is 10.3 As on 13 May, 2024 | 14:19